Advancements in Targeted Immunotherapy for Skin Disorders and Cancer

Physicians in the field of dermatology face the ongoing challenge of finding effective therapies that meet patient needs. Recent breakthroughs in understanding the immunopathogenesis of various cutaneous disorders have led to significant developments in targeted immunotherapy. These advancements have resulted in improved patient outcomes, as these newer therapies are being used for both approved indications and off-label treatments for chronic inflammatory skin disorders and skin cancer.

Understanding the safety profile of these targeted therapies is crucial for improving patient outcomes. This publication provides insights into topics such as adverse reactions, infectious complications, and the perioperative use of biologics in psoriasis, immunogenicity of biologic therapies, paradoxical reactions, safety of biologics used to treat autoimmune bullous diseases and primary cutaneous lymphomas, adverse reactions and skin manifestations of therapies targeting melanoma and non-melanoma skin cancer, and other neoplastic diseases.

Eminent researchers with extensive clinical experience have contributed to this publication, providing an in-depth overview of the latest knowledge in this field. This book offers a comprehensive guide for healthcare professionals seeking to understand the latest advancements in targeted immunotherapy for skin disorders and cancer.

Publication Details:

Series: Current Problems in Dermatology, Vol. 53

Pages: 108

Publisher: S. Karger

Publication Date: November 30, 2017

Language: English

ISBN-10: 331806100X

ISBN-13: 978-3318061000